Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induced-T Cell Like NK Cellular Immunotherapy for Refractory B Cell Malignancies

NCT04747093 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT04747093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04747093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induced-T Cell Like NK Cellular Immunotherapy for Refractory B Cell Malignancies
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 29, 2021
Completion date
March 31, 2022
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b cell leukemia, b cell lymphoma, b-cell acute lymphoblastic leukemia, b-cell lymphoma recurrent, b-cell lymphoma refractory